Show
Sort by
-
The chromosome 17q super-enhancer landscape in neuroblastoma
-
- Conference Paper
- C3
- open access
Long non-coding RNAs as novel components in the TP53 pathway
-
Dual targeting of ALK and RET: establishing a novel basis for the treatment of neuroblastoma
-
Dual targeting of ALK and RET: establishing a novel basis for the treatment of neuroblastoma
-
The HBP1 tumor suppressor is an epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex
-
ETV5 functionally connect ALK and CXCR4 signaling in neuroblastoma
-
The TBX2 super-enhancer marked transcription factor on 17q is overexpressed in neuroblastoma and infers poor prognosis
-
Sensing mutant ALK: Capicua and ETV5 as executors of aberrant ALK-driven MAPK signaling
-
The HBP1 tumor suppressor is a negative epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex
-
The HBP1 tumor suppressor is a negative epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex